-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Letrazuril
Category | Human immunodeficiency Virus (HIV) |
CAS | 103337-74-2 |
Description | Letrazuril is an anti-HIV agent. It is also an antiprotozoal agent that is effective against cryptosporidium infections. |
Product Information
Synonyms | 2-(2,6-Dichloro-4-(3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)phenyl)-2-(4-fluorophenyl)acetonitrile; Benzeneacetonitrile, 2,6-dichloro-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-α-(4-fluorophenyl)-; (±)-(2,6-Dichloro-4-(4,5-dihydro-3,5-dioxo-as-triazin-2(3H)-yl)phenyl)(p-fluorophenyl)acetonitrile |
IUPAC Name | 2-[2,6-dichloro-4-(3,5-dioxo-1,2,4-triazin-2-yl)phenyl]-2-(4-fluorophenyl)acetonitrile |
Molecular Weight | 391.18 |
Molecular Formula | C17H9Cl2FN4O2 |
Canonical SMILES | C1=CC(=CC=C1C(C#N)C2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C=N3)Cl)F |
InChI | InChI=1S/C17H9Cl2FN4O2/c18-13-5-11(24-17(26)23-15(25)8-22-24)6-14(19)16(13)12(7-21)9-1-3-10(20)4-2-9/h1-6,8,12H,(H,23,25,26) |
InChIKey | XQKYUBTUOHHNDV-UHFFFAOYSA-N |
Purity | 95% |
Density | 1.54±0.1 g/cm3 |
Solubility | Soluble in DMSO |
Appearance | Solid Powder |
Storage | Store at 2-8°C for short term (days to weeks) or -20°C for long term (months to years) |
Complexity | 632 |
Exact Mass | 390.0086591 |
Index Of Refraction | 1.681 |
PSA | 91.80000 |
Target | HIV |
XLogP3-AA | 3.5 |